Business, energy, technology, markets and global industry news from Business News Today

Concord Biotech Limited

PharmaDeviceNews Concord Biotech Limited
Representative image of pharmaceutical quality control and drug manufacturing, reflecting Concord Biotech’s United States Food and Drug Administration approval for Mycophenolate Mofetil oral suspension and the market focus on its transplant immunosuppressant portfolio.
Pharma & Biotech

Can Mycophenolate Mofetil approval strengthen Concord Biotech’s United States generics strategy?

Find out how Concord Biotech’s FDA approval for Mycophenolate Mofetil could reshape its transplant generics strategy.

Read More